Telmisartan in high-risk patients intolerant of ACE inhibitors.

1 The Telmisartan Randomised AssesssmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators. Eff ects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008; 372: 1174–83. 2 Montori VM… CONTINUE READING